{"schema_version":"secwatch.filing_event.v1","accession":"0001485003-23-000020","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2023-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.197207+00:00","generated_at":"2026-06-20T03:40:49.099688+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Class action securities litigation settlement receives final court approval","bullets":["U.S. District Court for Southern District of New York granted final approval on January 31, 2023.","Settlement resolves consolidated shareholder class action In re Sesen Bio, Inc. Securities Litigation.","Derivative litigation previously received final approval by Massachusetts court on November 9, 2022.","Settlement terms were previously disclosed in August 2022 Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001485003-23-000020","json":"https://secwatch.observer/filing/0001485003-23-000020.json","markdown":"https://secwatch.observer/filing/0001485003-23-000020.md","text":"https://secwatch.observer/filing/0001485003-23-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000148500323000020/0001485003-23-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000148500323000020/sesn-20230131.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T03:40:49.099688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}